| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 09/25/2007 | US7273729 Chondroitin synthase and DNA encoding the enzyme |
| 09/25/2007 | US7273728 Fermenting an appropriate microorganism using glucose as a carbon source and operating two chromatographic separation steps wherein ion exchange chromatography is followed by hydrophobic interaction chromatography, wherein the diphtheria toxin has a purity of at least 98%. |
| 09/25/2007 | US7273727 Eukaryotic host cell containing a nucleic acid sequence coding for a bivalent or a multivalent glycosylated compound having two or more single polypeptide chain antigen binding regions linked to a prodrug-activating enzyme; transgenic nonhuman mammal having the sequence |
| 09/25/2007 | US7273726 Compounds, compositions and methods for the treatment of diseases characterized by A-33 related antigens |
| 09/25/2007 | US7273725 Human and mammalian stem cell-derived neuron survival factors |
| 09/25/2007 | US7273724 Also producing the polypeptide by DNA recombinant technology |
| 09/25/2007 | US7273723 A system for antibiotic-regulated gene expression in eukaryotic cells, based on sequences from Enterobacteriaceae antibiotic resistance promoters, polypeptides that bind to the same in an antibiotic- responsive manner |
| 09/25/2007 | US7273722 Insertion of cleavage sites in non-critical regions of the toxins which are susceptible to protease activity in non-target tissues and single chain forms activated by proteases in the target; botulism and tetanus toxins; confine activity to target site; side effect reduction |
| 09/25/2007 | US7273721 Used in identification of microorganisms which can be used to produce fine chemicals, the modulation of fine chemical production in C. glutamicum or related bacteria, the typing or identification of C. glutamicum as transformation markers |
| 09/25/2007 | US7273718 Isolated genomic polynucleotide fragments from chromosome 10q25.3 that encode human soluble aminopeptidase P |
| 09/25/2007 | US7273706 Decreased expression level of the protein in said test sample relative to the expression level of the protein in a normal sample is indicative of a testicular tumor or a predisposition to a testicular tumor. |
| 09/25/2007 | US7273704 Involving monitoring outputs from nucleic acid probe parts due to hybridization between a nucleic acid probe and the specific nucleic acid to determine frequency distribution of times when the outputs exceed a predetermined value with respect to each of the probes parts |
| 09/25/2007 | US7273703 Detection of mutations |
| 09/25/2007 | US7273701 Compositions and methods for genetic analysis of polycystic kidney disease |
| 09/25/2007 | US7273698 Defects in periaxin associated with myelinopathies |
| 09/25/2007 | US7273697 Method for analyzing base sequence of nucleic acid |
| 09/25/2007 | US7273696 Kits for the detection of target sequences |
| 09/25/2007 | US7273695 HIV immunoassays using synthetic envelope polypeptides |
| 09/25/2007 | US7273614 Inhibitory of human and non-human retroviral, especially HIV, transmission to uninfected cells. |
| 09/25/2007 | US7273612 Soluble inhibitors of vascular endothelial growth factor and use thereof |
| 09/25/2007 | US7273611 Proteinase K resistant surface protein of neisseria meningitidis |
| 09/25/2007 | US7273609 Methods for treating autoimmune and chronic inflammatory conditions using antagonists of CD30 or CD30L |
| 09/25/2007 | US7273608 Humanized anti-CEA T84.66 antibody and uses thereof |
| 09/25/2007 | US7273605 Containing a priming and boosting composition, each with a non-replicating viral vector, with at least one of them being derived from a fowlpox virus; malaria, tuberculosis |
| 09/25/2007 | CA2415786C Transposon mediated multiplex sequencing |
| 09/25/2007 | CA2362545C Protection probes |
| 09/25/2007 | CA2357732C Raman optrode processes and devices for detection of chemicals and microorganisms |
| 09/25/2007 | CA2294649C Bovine adenovirus type 3 genome |
| 09/25/2007 | CA2263716C Covalent joining of dna strands to rna strands catalyzed by vaccinia topoisomerase |
| 09/25/2007 | CA2253021C New mutants of formate dehydrogenase from candida boidinii, new gene sequences encoding these and use of the new formate dehydrogenases |
| 09/25/2007 | CA2239979C Novel starches via modification of expression of starch biosynthetic enzyme genes |
| 09/25/2007 | CA2214018C An immortalized mammal hybridoma fusion partner |
| 09/25/2007 | CA2204160C Treatment of urogenital cancer with boron neutron capture therapy |
| 09/25/2007 | CA2192442C Complementary adenoviral vector systems and cell lines |
| 09/25/2007 | CA2183758C Human papilloma virus detection in a nucleic acid amplification process using general primers |
| 09/25/2007 | CA2173592C Stem cell proliferation factor |
| 09/25/2007 | CA2128109C Improvements in or relating to malaria vaccine |
| 09/22/2007 | CA2582272A1 System for regulated and enhanced baculovirus mediated transient transgene expression in mammalian cells |
| 09/21/2007 | CA2582969A1 Process for producing 4-vinylguaiacol by biodecarboxylation of ferulic acid |
| 09/20/2007 | WO2007106905A2 Polyunsaturated fatty acid production in heterologous organisms using pufa polyketide synthase systems |
| 09/20/2007 | WO2007106904A2 Plant seed oils containing polyunsaturated fatty acids |
| 09/20/2007 | WO2007106903A2 Polyunsaturated fatty acid production in heterologous organisms using pufa polyketide synthase systems |
| 09/20/2007 | WO2007106728A2 Soybean seed and oil compositions and methods of making same |
| 09/20/2007 | WO2007106552A2 System and method for diagnosis of infectious diseases |
| 09/20/2007 | WO2007106448A1 Methods for making antibodies in genetically engineered mice |
| 09/20/2007 | WO2007106424A2 Treating cancers with activated ras through inhibition of pkc delta |
| 09/20/2007 | WO2007106407A2 Microarray for monitoring gene expression in multiple strains of streptococcus pneumoniae |
| 09/20/2007 | WO2007106136A2 Method and apparatus for avalanche-mediated transfer of agents into cells |
| 09/20/2007 | WO2007106073A2 Modified pathogens for use as vaccines |
| 09/20/2007 | WO2007106048A1 A system for inhibiting pathogenicity in the rice-blast fungus magnaprothe grisea |
| 09/20/2007 | WO2007106047A1 Nucleic acid interaction analysis |
| 09/20/2007 | WO2007106041A1 Polyketides and uses thereof |
| 09/20/2007 | WO2007105967A1 Novel plant genes and uses thereof |
| 09/20/2007 | WO2007105965A1 Solution pre-treatment for use in dna amplification reactions |
| 09/20/2007 | WO2007105797A1 Novel human t cell population |
| 09/20/2007 | WO2007105786A1 Method of detecting nucleic acid and nucleic acid detection kit |
| 09/20/2007 | WO2007105744A1 Purkinje cell-tropic viral vector |
| 09/20/2007 | WO2007105676A1 Microchip and soi substrate for manufacturing microchip |
| 09/20/2007 | WO2007105673A1 Method for detection of mutant gene |
| 09/20/2007 | WO2007105623A1 Oligonucleotide-immobilized solid support |
| 09/20/2007 | WO2007105565A1 Peptide for inhibition of influenza infection, inhibitor of influenza infection, liposome, and prophylactic/therapeutic agent for influenza |
| 09/20/2007 | WO2007105528A1 Transfection device |
| 09/20/2007 | WO2007105350A2 Catalase gene and use thereof |
| 09/20/2007 | WO2007105321A1 NOVEL β-GALACTOSIDE α2,6-SIALYLTRANSFERASE, GENE CODING FOR THE TRANSFERASE AND PROCESS FOR PRODUCING THE SAME |
| 09/20/2007 | WO2007105305A1 NOVEL β-GALACTOSIDE-α2,6-SIALYLTRANSFERASE, GENE ENCODING THE SAME AND METHOD FOR PRODUCING THE SAME |
| 09/20/2007 | WO2007105002A2 Nucleic acid molecules involved or associated with abscission |
| 09/20/2007 | WO2007104979A1 Virus-like particles of rift valley fever virus |
| 09/20/2007 | WO2007104835A1 Use of a growth-stimulating protein |
| 09/20/2007 | WO2007104782A1 Recombinant newcastle disease virus expressing h5 hemagglutinin of avian influenza virus |
| 09/20/2007 | WO2007104739A1 Promoter mutations that increase amyloid precursor protein expression |
| 09/20/2007 | WO2007104633A1 A self-inactivating recombinant lentiviral vector for the inhibition of hiv replication |
| 09/20/2007 | WO2007104581A1 Use of recombinant modified vaccinia virus ankara (mva) for the treatment of type 1 hypersensitivity in a living animal including humans |
| 09/20/2007 | WO2007104570A2 Nematode control |
| 09/20/2007 | WO2007104427A1 Chimeric polypeptide molecule |
| 09/20/2007 | WO2007104263A1 An enhancin of hepatitis b virus vaccine and its gene |
| 09/20/2007 | WO2007104181A1 Uses of dkk-1 protein in diagnosis of cancers |
| 09/20/2007 | WO2007090073A3 Oligomeric compounds and compositions for the use in modulation of micrornas |
| 09/20/2007 | WO2007071994A3 Viral vectors |
| 09/20/2007 | WO2007070996A3 Liga and ligb proteins (leptospiral ig-like (lig) domains) for vaccination and diagnosis |
| 09/20/2007 | WO2007070705A3 Cationic lipid-mediated vectors |
| 09/20/2007 | WO2007063311A3 Competitive domain antibody formats that bind interleukin 1 receptor type 1 |
| 09/20/2007 | WO2007063308A3 Noncompetitive domain antibody formats that bind interleukin 1 receptor type 1 |
| 09/20/2007 | WO2007058527A3 Inducible expression systems |
| 09/20/2007 | WO2007056114B1 Compositions and methods for the detection of trypanosoma cruzi infection |
| 09/20/2007 | WO2007047459A8 Rabies virus vector systems and compositions and methods thereof |
| 09/20/2007 | WO2007047301A3 Selective posttranslational modification of phage-displayed polypeptides |
| 09/20/2007 | WO2007042899B1 Human microrna targets in hiv genome and a method of identification thereof |
| 09/20/2007 | WO2007041513A3 Conserved membrane activator of calcineurin (cmac), a novel therapeutic protein and target |
| 09/20/2007 | WO2007027338A3 Biosynthesis and delivery of therapeutic compounds |
| 09/20/2007 | WO2006097945A3 A method for achieving high-level expression of recombinant human interleukin-2 upon destabilization of the rna secondary structure |
| 09/20/2007 | WO2006047469A8 Polypeptides having lipase activity and polynucleotides encoding same |
| 09/20/2007 | WO2006025059A3 Salt resistant transgenic plants |
| 09/20/2007 | WO2005122697A3 Transgenic plants containing a dehydrin gene |
| 09/20/2007 | WO2005120152A3 Cationic lipids and methods of use |
| 09/20/2007 | WO2005115135A3 Mouse model of crohn’s disease and a method to develop specific therapeutics |
| 09/20/2007 | WO2005023995A3 Chimeric oligomeric compounds comprising alternating regions of northern and southern conformational geometry |
| 09/20/2007 | WO2004069176A3 Polymer conjugates of mutated neublastin |
| 09/20/2007 | WO2003011823A3 Crfr1 selective ligands |
| 09/20/2007 | US20070220635 Catalyses the 2 beta -oxidation of a gibberellin molecule to introduce a hydroxyl group at C-2 and further catalyses the oxidation of the hydroxyl group introduced at C-2 to yield the ketone derivative; transgenic plants with improved or altered growth characteristics; agriculture; horticulture |
| 09/20/2007 | US20070220634 Plant seed oils containing polyunsaturated fatty acids |